Dr. Sorrell on Vitality Unfiltered with David J. Bauder, PA-C (November 2026, 30 min). His follow-up episode, on what in longevity medicine actually works, is summarized in Longevity Medicine: What Works vs. What’s Hype.

Dr. Sorrell walked through this checklist with David J. Bauder, PA-C, on the Vitality Unfiltered podcast in November 2026 (the full episode is above). His short version is three questions; the detailed six-point checklist and his approach to monitoring follow.

What “Online TRT Clinic” Usually Means

Telemedicine hormone care vs brick-and-mortar

An online TRT clinic typically means hormone evaluation and prescribing through video or remote visits, with labs drawn locally and medication shipped or filled through a partner pharmacy. Brick-and-mortar care happens in a physical office. Both models can be careful. Both models can cut corners.

What matters is not the webcam. It is whether a licensed clinician reviews your history, orders appropriate baseline and monitoring labs, explains risks, and plans follow-up. Telemedicine is a delivery channel. It is not a quality guarantee.

TRT-focused mills vs comprehensive hormone / metabolic care

Some practices market only testosterone. Volume, speed, and “start today” language often come first. Comprehensive hormone or metabolic care looks wider: symptoms, cardiometabolic risk, body composition goals, fertility plans, and related labs — then a shared decision about whether hormone therapy belongs in the plan at all.

If a clinic’s only product is a vial and a refill calendar, treat that as a signal. You may still get a prescription. You may not get medical judgment.

Are Online TRT Clinics Legit?

Short answer: Some are careful; some are not. Legitimacy is not about “online” vs “in person.” It is about who cares for you, how they evaluate you, and where they are licensed to practice.

Legitimate telemedicine exists — legitimacy is about who, how, and where licensed

Physician-led TRT telemedicine and HRT telemedicine can be appropriate for selected patients when state licensing, clinical evaluation, labs, pharmacy transparency, and monitoring are in place. Online care is not automatically unsafe. It is also not automatically safe.

Ask: Is the clinician licensed in your state? Who reviews your labs? What happens if side effects appear? How are dose changes handled? Vague answers are data.

Red flags: no MD involvement, no baseline labs, pressure to buy pellets, vague pharmacy

Watch for:

  • No clear MD involvement, or a pipeline that funnels you past a clinician who never owns the plan
  • “No labs needed” or a single total testosterone as the whole workup
  • High-pressure pellet or package upsells before a real assessment
  • Unclear pharmacy or compounding source (“we’ll ship something” with no details)
  • Dose changes by chat alone, with no scheduled follow-up

None of these prove crime. They do prove you should slow down.

The Short Version: Three Questions to Ask

On the podcast, Dr. Sorrell narrowed the vetting process to three questions:

  1. Is the prescriber experienced and trained in hormones? Many physicians, Dr. Sorrell included, got little hormone education in residency; through the 2000s and 2010s hormones were mostly taught as something to avoid. Ask whether the clinician has completed advanced hormone training or has substantial experience, and whether they say so plainly.
  2. Is the evaluation personal, or just a questionnaire? A few checkboxes and one blood test will approve some men who genuinely benefit, but they can also miss why testosterone is low. Sleep apnea, excess body fat and diet are common drivers, and sometimes they should be addressed first.
  3. Is there ongoing monitoring? Refills are not monitoring. Someone should be checking in on how you feel and reviewing labs, including estradiol, PSA and hematocrit, because testosterone has side effects that need to be caught early.

The opposite failure is the cookie-cutter protocol. Some clinics put every patient on an aromatase inhibitor to block estrogen, which in some men drives estradiol close to zero, a problem of its own.

Decision Framework — 6 Checks Before You Book

Use this as a pass/fail filter for any online TRT clinic or hormone telemedicine practice.

  1. State medical license (yours and the clinician’s) — confirm current list

    Telemedicine follows state medical practice rules. The clinician generally needs a license where you are located when care is delivered. Ask for the clinician’s name and license state. Confirm whether the practice currently treats patients in your state.

    Licenses change. Marketing pages go stale. Always confirm the current list before you book — including on a discovery call.

  2. Who actually manages you (MD vs PA/NP-only pipeline)

    Advanced practice clinicians can provide excellent care in many settings. For hormone therapy, ask who owns your plan, who interprets complex labs, and who you speak with when something is wrong.

    A useful question: “If my symptoms change, who do I see — and how often?” If the answer is a rotating queue with no named physician accountability, factor that into your decision. Some patients specifically want direct MD care. That preference is reasonable.

  3. DEA / controlled-substance & telemed rules (high-level only)

    Some hormone therapies involve controlled substances. Federal and state rules affect how prescribing and telemedicine interact. This article is not legal advice. Do not treat forums as compliance manuals. Do not look for workarounds.

    What you can ask a clinic, at a high level: Do you prescribe controlled substances via telemedicine where allowed? How do you document medical necessity? What follow-up is required? If a clinic brags about “no rules” or “easy scripts,” walk away.

  4. Labs: baseline + monitoring depth (not a single total T)

    A single total testosterone number is a thin foundation. Thoughtful hormone care usually includes a broader baseline and a monitoring plan — how often, which markers, and what would change the plan. Depth varies by patient and goals. Clinics that skip meaningful labs are a red flag.

    Deep lab panels (for example, programs that review 100–200+ biomarkers) are one way clinics show they are looking beyond a marketing number. More labs are not always better in isolation. Context and follow-up matter more than a PDF dump.

  5. Pharmacy / compounding transparency

    Ask where medication comes from. Is it a retail pharmacy, a compounding pharmacy, or a third-party fulfillment partner? Can they name the pharmacy? Do they discuss formulation, storage, and monitoring needs in plain English?

    Transparency does not mean perfection. Opacity is the problem. “Trust us, it ships” is not a care plan.

  6. Follow-up: visit cadence, messaging, dose changes without check-ins

    Hormone therapy is not a one-time checkout. Ask about visit cadence, how you reach the team between visits, and whether dose changes require a clinical touchpoint.

    Red flag: automatic escalations with no check-in. Green flag: scheduled visits, clear messaging access, and a plan for adverse effects. Programs that include monthly visits plus unlimited messaging make accountability easier to verify — ask how yours works before you pay.

Treat the Patient and the Number

Dr. Sorrell doesn’t treat a lab value alone, and he doesn’t treat symptoms alone. He looks for a testosterone level in the lower part of the range together with symptoms that fit. The most specific pattern he sees is a man in his late 30s or 40s who has trained for years and suddenly can’t lean out or build muscle the way he used to, often with more abdominal fat and lower energy or libido. Low libido, erectile dysfunction and fatigue on their own are less specific.

In his experience, a man with total testosterone in the 400s and that whole picture can respond dramatically to a modest dose, with the goal of restoring what is missing, never pushing levels above the physiologic range. That is a clinical judgment, not a guideline threshold: the Endocrine Society defines deficiency by consistently low morning levels (its reference range starts at about 264 ng/dL) plus symptoms.1 A decision like that belongs in a careful conversation with a physician, not a questionnaire. Total testosterone can also mislead; see free vs total testosterone.

He also values patient autonomy. He is willing to try a therapy a patient wants if it is safe, there is a plausible benefit, and that benefit outweighs the risk after an honest discussion, with an agreement on monitoring and how long to continue.

What Monitoring Should Look Like on TRT

Dr. Sorrell’s routine for men starting testosterone:

  • Labs about 6 to 8 weeks after starting, because the first dose is a best estimate and usually needs adjusting.
  • Another check 6 to 8 weeks after any dose change.
  • Once levels are stable, labs every 3 to 6 months: every 3 months if hematocrit or PSA is drifting up, every 6 months if everything is steady.

That is tighter than the Endocrine Society guideline, which checks testosterone and hematocrit at 3 to 6 months and then yearly, and recommends stopping therapy if hematocrit rises above 54% until it comes back down.1 In the large TRAVERSE trial, testosterone did not increase major cardiovascular events in men with low testosterone and elevated cardiovascular risk, but atrial fibrillation, acute kidney injury and pulmonary embolism were more common.2 Regular monitoring is how those problems get caught. A clinic that cannot tell you its monitoring schedule before you start is answering check 6 for you.

A Note for Women: Menopause Hormone Therapy

The same vetting applies to HRT telemedicine. Much of Dr. Sorrell’s practice is adults over 40, and most of them, men and women, end up on some form of hormone therapy. A generation of women lost access after the 2002 Women’s Health Initiative report. That trial studied older women (average age 63) on conjugated equine estrogens plus medroxyprogesterone, not today’s bioidentical options, and even so it found fewer hip fractures and colorectal cancers.3 Starting near menopause carries much lower risk than starting years later.

In November 2025 the FDA began removing the boxed warning about heart disease, breast cancer and dementia from menopause hormone therapy labels, and it approved the first relabeled products in February 2026; the endometrial cancer warning stays on estrogen-only products.4 There is still no FDA-approved testosterone product for women in the U.S., so compounded options fill that gap. More in Testosterone and Menopause HRT and Online Perimenopause Treatment.

Questions to Ask Any Online Hormone Clinic

Copy this checklist. Ask before you commit.

  • Are you licensed to treat patients in my state right now? Can you confirm the clinician’s name and license?
  • Who will manage my care — MD, PA, NP, or a rotating team?
  • What baseline labs do you require before considering therapy?
  • What monitoring labs do you use after therapy starts, and how often?
  • Where is medication dispensed or compounded?
  • How do you handle controlled-substance prescribing via telemedicine (high-level process, not loopholes)?
  • What is the visit schedule? How do I message the team between visits?
  • How are dose changes decided? Is there a clinician review?
  • What is included in the monthly fee — visits, messaging, lab interpretation?
  • If fertility, cardiovascular risk, or complex symptoms are in play, how do you handle specialist referral?

If answers are vague, sales-heavy, or hostile to questions, keep shopping.

If fertility is still part of the decision, the companion framework is Enclomiphene vs TRT When Fertility Still Matters.

How Sorrell MD Approaches Hormone Telemedicine

Sorrell MD is the practice of Luke Sorrell, MD FACP — an ABIM board-certified internist, with an A4M Longevity Medicine Fellowship (June 2026) and Peptavo Certified Clinician credentials. Care is 100% telemedicine where licensed: Texas plus most other U.S. states. Please contact the practice to confirm your state before booking.

How this practice is set up:

  • Direct MD care — never a PA. You work with Dr. Sorrell.
  • Deep labs in the range of 100–200+ biomarkers, interpreted in clinical context.
  • Programs include monthly visits plus unlimited messaging.
  • Hormone / Body Composition / Metabolic & Peptides program: $299/mo.
  • Direct-pay; HSA/FSA eligible; superbills available.
  • Related programs on the site include Gut Optimization and Cardiovascular Risk. Longevity care is available as a separate annual or monthly option when that is the right fit — not every hormone patient needs it.

This is not a claim that Sorrell MD is right for everyone. It is a description of the model so you can compare against the six checks above. Start at Sorrell MD, or see the Hormone, Body Composition & Metabolic guide.

When to Book a Discovery Call vs Keep Shopping

Book a free 30-minute discovery call when

  • You want MD-led hormone or metabolic care, not a refill mill
  • You have labs (or are willing to get them) and want a structured review
  • Fertility, body composition, or metabolic goals matter alongside symptoms
  • You need to confirm whether your state is currently covered

Keep shopping when

  • You only want the cheapest script with no follow-up
  • You are unwilling to do labs or discuss history
  • You need an in-person procedure or specialist service this practice does not provide
  • A clinic cannot confirm licensing in your state

Bring current labs and questions about state access. On the call, we confirm licensing and whether MD-led hormone care is a fit. A discovery call is not a prescription visit and does not guarantee therapy.

If you want a calm, MD-led review of whether online hormone care fits your goals, book a free 30-minute discovery call. Bring your current labs and questions about state access — we’ll confirm licensing and whether MD-led hormone care is a fit.

Educational content only. Not medical advice. Individual decisions require personal clinical evaluation.

Frequently asked questions

Are online TRT clinics legit?

Some are physician-led and appropriately licensed; others operate as volume mills. Legitimacy depends on license, labs, pharmacy, and follow-up — use the checklist in this article.

What's the difference between TRT telemedicine and HRT telemedicine?

TRT typically refers to testosterone therapy (often marketed to men); HRT telemedicine is broader (including menopause care). Vetting standards — license, labs, MD involvement — apply to both.

Do I need bloodwork before starting testosterone online?

Appropriate baseline and monitoring labs are a core safety signal. Clinics that skip meaningful labs are a red flag. This is educational guidance, not a lab protocol.

Can I get hormone care if I don't live in Texas?

Sorrell MD is 100% telemedicine and serves Texas plus most other U.S. states. Contact the practice or book a discovery call to confirm your state.

Who will I actually see at Sorrell MD?

Direct MD care with Luke Sorrell, MD FACP — never a PA. Programs include monthly visits and unlimited messaging.

How often should labs be checked on TRT?

Dr. Sorrell checks labs about 6 to 8 weeks after starting and after any dose change, then every 3 to 6 months once levels are stable. The Endocrine Society guideline checks testosterone and hematocrit at 3 to 6 months and then yearly.

What labs should be monitored on testosterone therapy?

At minimum testosterone, estradiol, hematocrit and PSA (for men in the screening age range), alongside a check-in on symptoms. The Endocrine Society recommends stopping therapy if hematocrit rises above 54% until it comes back down.

References

  1. Bhasin S, Brito JP, Cunningham GR, et al. “Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline.” Journal of Clinical Endocrinology & Metabolism (2018). DOI: 10.1210/jc.2018-00229

  2. Lincoff AM, Bhasin S, Flevaris P, et al. “Cardiovascular safety of testosterone-replacement therapy.” New England Journal of Medicine (2023). DOI: 10.1056/NEJMoa2215025

  3. Rossouw JE, Anderson GL, Prentice RL, et al. “Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial.” JAMA (2002). DOI: 10.1001/jama.288.3.321

  4. U.S. Food and Drug Administration. “FDA Approves Labeling Changes to Menopausal Hormone Therapy Products.” February 12, 2026. fda.gov

  5. Vitality Unfiltered with David J. Bauder, PA-C. “Online Testosterone Clinics: Are You Getting Real Medical Care? | Dr. Luke Sorrell.” November 2, 2026. youtube.com